Polychlorinated biphenyls (PCBs) and dioxins are persistent environmental pollutants that occur in the environment. They have varying influences on the human body. Some harmful influences of prenatal and/or postnatal exposure to PCBs and dioxins on the neurodevelopment of infants have previously been shown. Longitudinal studies have also been performed in both low-level (background-level) dioxin-contaminated areas and high-level contaminated areas to demonstrate the effects of these pollutants on the neurodevelopment of children.

Dozens of studies in background-level contaminated areas have been performed since the latter half of the 1980s, such as the North Carolina (USA) study ([@b6-ehp0114-000773]; [@b7-ehp0114-000773], [@b5-ehp0114-000773]; [@b23-ehp0114-000773]; [@b24-ehp0114-000773]), the Netherlands two-cities study ([@b10-ehp0114-000773], [@b11-ehp0114-000773]; [@b15-ehp0114-000773]; [@b16-ehp0114-000773]; [@b22-ehp0114-000773]; [@b28-ehp0114-000773], [@b30-ehp0114-000773], [@b29-ehp0114-000773], [@b31-ehp0114-000773]), the Düsseldorf, Germany, study ([@b32-ehp0114-000773]; [@b34-ehp0114-000773]), and the U.S. 11-cities study ([@b4-ehp0114-000773]; [@b8-ehp0114-000773]). The Bayley Scales of Infant Development (BSID) or the BSID second edition (BSID-II) was used in all of these studies to evaluate infants' mental or motor development. As a result, the prenatal and/or postnatal exposure was shown to have a significant negative association with motor development during infancy, whereas significant associations were not found in young children ([@b6-ehp0114-000773]; [@b7-ehp0114-000773]; [@b15-ehp0114-000773]; [@b22-ehp0114-000773]; [@b23-ehp0114-000773]; [@b28-ehp0114-000773], [@b29-ehp0114-000773]). On the other hand, only one study showed a significant negative association between postnatal exposure and the cognitive development of young children ([@b32-ehp0114-000773]). In addition, another study showed a positive association between prenatal exposure and motor development during infancy in some of the diverse study sites across the United States ([@b4-ehp0114-000773]).

Thus, consistent results relating to the influence of background-level dioxin exposure on children's development have not been obtained. [@b18-ehp0114-000773] suggested that interpretation of human data regarding low-level, early-life PCB exposure and subsequent neurodevelopment was problematic because levels of exposure were not similarly quantified across studies.

In Japan, [@b25-ehp0114-000773] examined the mental development of 1-year-old breast-fed infants and bottle-fed infants and reported that their mental development was within a normal range. However, this report was not based on detailed developmental tests such as BSID. [@b19-ehp0114-000773] examined the association between hexachloro-cyclohexane, heptachlor epoxide, chlordane, dieldrin, dichlorodiphenyltrichloroethane (DDT), PCBs, or dioxin in breast milk and the development of infants at 10 months. In that study, the authors evaluated the associations using the Enjohji Scales of Infant Development and reported that a significant negative association existed between PCBs and the development of comprehension. The developmental tests that were used in these two studies were different from those of previous studies, and it was not possible to perform detailed evaluations. An additional problem was that detailed exposure measurements had not been performed in these studies.

The aim of the present study was to examine the influence of environmental chemicals such as PCBs and dioxins on the mental and motor development of infants of the next generation in Sapporo, Japan. Consequently, we carried out detailed measurements of the levels of PCBs and dioxins in the mothers' peripheral blood and performed neurodevelopmental assessments of their 6-month-old infants using BSID-II to examine the influence of prenatal exposure of these pollutants on the neurodevelopment of infants.

Materials and Methods
=====================

Study population.
-----------------

We recruited pregnant women between July 2002 and July 2004 from the Sapporo Toho Hospital in Hokkaido, Japan (this study became known as the Hokkaido Study on Environment and Children's Health). All the subjects were native Japanese and were resident in Sapporo and the surrounding areas. The subjects completed the self-administered questionnaire survey after the second trimester during their last pregnancy. The questionnaire provided information relating to their dietary habits, exposure to chemical compounds in their daily life and at their work site, home environment, smoking, and medical histories of themselves and their partners. The prenatal information of the mothers and their children was collected from their medical records. This study was conducted with all the subjects' written informed consent and was approved by the institutional ethical board for epidemiologic studies at Hokkaido University Graduate School of Medicine.

Exposure measures.
------------------

A 40-mL blood sample was taken from the maternal peripheral vein after the second trimester during their last pregnancy. When we were not able to take mother's blood due to the mother's anemia during pregnancy, we took the blood during hospitalization after delivery. All samples were stored at −80°C until analysis.

The concentrations of PCBs and dioxins in the maternal blood were measured using high-resolution gas chromatography/high-resolution mass spectrometry (HRGC/HRMS) equipped with a solvent-cut large-volume injection system (SGE Ltd., Victoria, Australia) at Fukuoka Institute of Health and Environmental Sciences. The gas chromatograph was an Agilent 6890 (Agilent Technologies Inc., Palo Alto, CA, USA) equipped with an AutoSpec-Ultima NT (Micromass Ltd., Manchester, UK). The levels of PCBs and dioxins were measured in each isomer \[seven polychlorinated dibenzo-*p*-dioxins (PCDDs): 2,3,7,8-tetrachlorodibenzo-*p*-dioxin (TCDD), 1,2,3,7,8-pentachlorodibenzo-*p*-dioxin (PeCDD), 1,2,3,4,7,8-hexachlorodibenzo-*p*-dioxin (HxCDD), 1,2,3,6,7,8-HxCDD, 1,2,3,7,8,9-HxCDD, 1,2,3,4,6,7,8-hep-tachlorodibenzo-*p*-dioxin (HpCDD), octachlorodibenzo-*p*-dioxin (OCDD); 10 polychlorinated dibenzofurans (PCDFs): 2,3,7,8-tetrachlorodibenzofuran (TCDF), 2,3,7,8-pentachlorodibenzofuran (PeCDF), 2,3,4,7,8-PeCDF, 1,2,3,4,7,8-hexachloro-dibenzofuran (HxCDF), 1,2,3,6,7,8-HxCDF, 2,3,4,6,7,8-HxCDF, 1,2,3,7,8,9-HxCDF, 1,2,3,4,6,7,8-heptachlorodibenzofuran, 1,2,3,4,7,8,9-HpCDF, octachlorodibenzo-furan (OCDF); four non-*ortho* PCBs: 3,3′,4′,4′-tetracholorobiphenyl (TCB) (congener 77), 3,4,4′,5-TCB (congener 81), 3,3′,4,4′,5-pentachlorobiphenyl (PeCB) (congener 126), 3,3′,4,4′,5,5′-hexachlorobiphenyl (HxCB) (congener 169); eight mono-*ortho* PCBs: 2,3,3′4,4′-PeCB (congener 105), 2,3,4,4′,5-PeCB (congener 114), 2,3′,4,4′,5-PeCB (congener 118), 2′,3,4,4′,5-PeCB (congener 123), 2,3,3′,4,4′,5-HxCB (congener 156), 2,3,3′,4,4′,5′-HxCB (congener 157), 2,3′,4,4′5,5′-HxCB (congener 167), 2,3,3′,4,4′,5,5′-heptachlorobiphenyl (HpCB) (congener 189); and two di-*ortho* PCBs: 2,2′3,3′,4,4′,5-HpCB (congener 170), 2,2′,3,4,4′,5,5′-HpCB (congener 180)\], and the total toxicity equivalency quantity (TEQ) levels were calculated ([@b12-ehp0114-000773]; [@b26-ehp0114-000773]). Furthermore, for several subjects, 68 PCBs (including mono-*ortho* PCBs), which remained behind in the blood, were measured using HRGC/HRMS.

Developmental measures.
-----------------------

We used BSID-II ([@b2-ehp0114-000773]) to assess the infants' mental and psychomotor development (mental, motor) at 6 months of age. BSID-II is a developmental test tool that is standardized for use in the United States and is most widely used as an infant assessment instrument in both clinical and research settings in the United States. The BSID-II mental scale assesses the age-appropriate children's level of cognitive, language, and personal/social development. The motor scale assesses fine and gross motor development. Mental and motor scores are based on the calibration scale from raw score and are represented as index scores. The mean values of the mental developmental index (MDI) and the psychomotor developmental index (PDI) were 100, and the standard deviation was 15. Although BSID-II has a lot of strengths and weaknesses ([@b2-ehp0114-000773]), it is a most useful test to measure the present attainment of developmental abilities of normal children ([@b3-ehp0114-000773]).

Because BSID-II was not standardized in Japan, we translated a BSID-II manual in consultation with a manual for BSID, which was used in the development study reported by [@b13-ehp0114-000773], [@b14-ehp0114-000773]. The children were brought to the community center in Sapporo, where they were tested in a quiet, private room in the presence of the parent(s) by one examiner. The development evaluation was performed by three occupational therapists who have clinical experience in the field of developmental disabilities. The examiners were unaware of the infants' PCB and dioxin exposure levels. First, for all examined children, the scoring was performed by the examiner who performed the examination, and then the scoring was double-checked by two other examiners based on a video that recorded the examination.

We investigated the environmental conditions of the subjects using the questionnaire of home environment devised by [@b1-ehp0114-000773].

Data analysis.
--------------

We used the following eligibility criteria for analysis of subjects: no serious illnesses or complications during pregnancy and delivery, singleton babies born at term (37--42 weeks' gestation), Apgar score of \> 7 at 1 min, infants without congenital anomalies or diseases, and BSID-II completed.

We performed multiple-regression analysis to examine the association between BSID-II scores (MDI, PDI) and the levels of PCBs and dioxins in maternal blood. The levels of PCBs and dioxins in maternal blood were logarithmically transformed, and the analysis was adjusted for gestational age (days), smoking during pregnancy, and caffeine intake during pregnancy (milligrams per day). When we examined the levels of PCBs and dioxins among blood sampling time (during pregnancy and after delivery) by the Mann-Whitney test, there were significant differences in the levels of OCDD (*p* \< 0.001), 1,2,3,4,6,7,8-HpCDD (*p* \< 0.001), total PCDDs (*p* \< 0.01), and total PCDDs/PCDFs (*p* \< 0.05) (data not shown). So the blood sampling time was adjusted in multiple regression analysis. Results were considered significant if *p* \< 0.05.

Results
=======

One hundred thirty-five mother--infant pairs fulfilled the determined eligibility criteria of this study; they completed exposure measurements and BSID-II. One pair was excluded from the study because the PCB and dioxin levels in the maternal blood were extremely high. So, in total, 134 mother--infant pairs were included in the study.

Characteristics of mothers and infants are presented in [Table 1](#t1-ehp0114-000773){ref-type="table"}. The mean (± SD) maternal age was 31.1 ± 4.7 years; 13.4% of mothers continued smoking during pregnancy. Forty-four percent of mothers ate inshore fish during pregnancy at least once per week, and 58.2% of mothers ate deep-sea fish during pregnancy at least once per week. Fifty percent of infants were first-born, and 58.2% of infants had been breast-fed \> 3 months. The mean scores of MDI and PDI were 91.9 ± 5.8 and 89.3 ± 10.5, respectively. Both values were lower than the standardized score.

The relationships between MDI and PDI scores and the subjects' characteristics are presented in [Table 2](#t2-ehp0114-000773){ref-type="table"}. For mothers' characteristics, caffeine intake during pregnancy was significantly negatively associated with PDI scores (*r* = −0.177, *p* = 0.04). For infants' characteristics, gestational age (days) was significantly positively associated with MDI scores (*r* = 0.178, *p* = 0.039) and PDI scores (*r* = 0.289, *p* = 0.001).

The levels of PCBs and dioxins (picogram per gram lipid) in maternal blood are presented in [Table 3](#t3-ehp0114-000773){ref-type="table"}. For subjects with a level below the detection limit, we used a value equal to half the detection limit ([@b17-ehp0114-000773]). The means (ranges) of levels of total PCDD/PCDF TEQ, total coplanar PCB TEQ, and total TEQ were 11.9 (2.1--31.2), 6.9 (1.1--22.2), and 18.8 (4.0--51.2) pg TEQ/g lipid, respectively. The mean level of dioxins in this study was slightly lower than that of the subjects in other studies of domestic areas with ages similar to that in this study. In addition, the median level of PCB-153 in the maternal blood of 64 subjects in this study was 22.9 ng/g lipid, which was lower than that in the previous study ([@b18-ehp0114-000773]).

[Table 4](#t4-ehp0114-000773){ref-type="table"} shows the results of the multiple regression analysis of the association between the levels of PCBs and dioxins in maternal blood and MDI and PDI scores. After adjustment for blood sampling time, gestational age (days), smoking during pregnancy, and caffeine intake during pregnancy (milligrams per day), PCDD isomer 1,2,3,4,6,7,8-HpCDD (*p* \< 0.05), total PCDDs (*p* \< 0.01), and total PCDDs/PCDFs (*p* \< 0.05) were significantly negatively associated with MDI. On the other hand, PCDD isomers 1,2,3,7,8,9-HxCDD (*p* \< 0.05) and 1,2,3,4,6,7,8-HpCDD (*p* \< 0.01), 2,3,7,8-TCDF (*p* \< 0.05), 1,2,3,7,8-PeCDF (*p* \< 0.05), and PCDF isomer 1,2,3,6,7,8-HxCDF (*p* \< 0.05) were significantly negatively associated with PDI. The total levels of PCBs and dioxins were not significantly associated with PDI, and the TEQ values were not significantly associated with MDI or PDI.

Discussion
==========

To the best of our knowledge, this is the first report to investigate the association between the early neurodevelopment of infants and the total level and individual isomer level of Japanese pregnant women's blood at background levels. As a result, there was no association between the TEQ value of the maternal blood and the PCB/dioxin level, whereas the levels of several isomers of dioxins were significantly negatively associated with mental or motor development. The total levels of PCDDs or PCDDs/PCDFs were significantly associated with mental development, whereas the levels of several specific isomers of PCDDs or PCDFs were associated with motor development.

In this study, the results of BSID-II were used as a neurodevelopment evaluation test for infants. The mean (± SD) MDI and PDI scores were 91.9 ± 5.8 and PDI 89.3 ± 10.5, respectively. Both scores were lower than the standardized scores (100). Because there is a cultural difference and a verbal difference between Japan and the United States, the BSID-II must be used with care in Japan. In particular, we should use standardized "classification" to judge how to treat or intervene with a child. However, the first BSID edition was used in Japan for developmental evaluation of children. In addition, [@b21-ehp0114-000773] reported that there was a high correlation between BSID-II and the Kyoto Developmental Test that was standardized in Japan. A study in Taiwan stated that reproducibility was high in BSID-II, even if there were cultural differences ([@b9-ehp0114-000773]). Evaluation of neurodevelopment was limited to 6-month-old infants, and all the examiners scored all the infant subjects. Therefore, the BSID-II scores of the subjects in this study were directly comparable with each other.

The mean (range) level of PCBs and dioxins in maternal blood was 18.8 (4.0--51.2) pg TEQ/g lipid in this study, lower than that of subjects in studies in other domestic areas ([@b33-ehp0114-000773]). [@b18-ehp0114-000773] reported that interpretation of human data regarding low-level, early-life PCB exposure and subsequent neurodevelopment was problematic because levels of exposure were not similarly quantified across studies. Therefore, the PCB levels across studies of neurodevelopment were expressed in a uniform manner using the median level of PCB-153 in maternal pregnancy serum. The median PCB-153 level in the U.S. 11-cities, the Düsseldorf, the Netherlands two-cities, and the North Carolina studies ranged from 80 to 140 ng/g lipid, which were within the range of background levels. The median level of PCB-153 in the maternal blood of 64 subjects in this study was 22.9 ng/g lipid, which was clearly a lower contamination level in comparison with the other studies.

In this study, there was no significant association between the TEQ values of maternal blood PCB/dioxin level and mental and motor development, whereas there were significant negative associations with the levels of some isomers of dioxins and mental and motor development. The total levels of PCDDs or PCDDs/PCDFs were significantly associated with mental development, whereas the levels of several specific isomers of PCDDs or PCDFs were associated with motor development. There are many previous studies ([@b7-ehp0114-000773]; [@b15-ehp0114-000773]; [@b32-ehp0114-000773]) that show negative influences on the motor development of infants and young children rather than on their mental development. Although we used only the total PCB level or TEQ value as the exposure index in previous studies, we measured various levels of isomers of PCBs or dioxins in this study. In this study, there were no significant negative associations between the total levels of PCBs and dioxins and mental or motor development, whereas there were significant negative associations between motor development and levels of isomers of PCDDs and PCDFs. In this respect, it was impossible to explain the mechanism of our findings because there were few human or animal experimental studies investigating the association between individual isomer levels of PCBs and dioxins and neurodevelopment. So, at low-level exposure, total, and total TEQ values had only a minimal effect on mental and motor development. However, we found that several specific chemical compounds would have an adverse influence on motor development, whereas total PCDDs or total PCDDs/PCDFs would have an adverse influence on mental development.

[@b8-ehp0114-000773] reported that the level of total PCBs in mothers in their study, which did not show a significantly negative association with the level of total PCBs and the outcome, was similar to those in other studies in which an adverse effect was found. On the other hand, the mixture of PCBs in their specimens was unusual compared with that in other studies. Levels of nonquantitated PCBs may also have varied in biologically significant ways. Thus, they speculated that they might have had a relatively benign mixture if the composition of PCBs affected neurotoxicity. Therefore, the minimal effect of total and total TEQ values on mental and motor development in this study might be caused by the composition of PCBs and dioxins.

In this study, we performed multiple-regression analysis to examine the association between BSID-II scores (MDI, PDI) and total and individual isomer level of PCBs and dioxins. Because we performed 45 statistical tests for MDI or PDI, this study had a multiple-testing problem. If we performed the Bonferroni adjustment for addressing the multiple-testing problem, all the significances would have disappeared. Furthermore, this study has a small sample size. These are the limitations of this study.

However, because the measurement of PCBs and dioxins is highly complicated and is too expensive, it is difficult to measure these compounds in a large number of subjects. In recent studies of the associations between background-level exposure to PCBs and dioxins and infant neurodevelopment ([@b15-ehp0114-000773]; [@b32-ehp0114-000773]), the sample size was similar to our study. However, no studies have measured isomer levels of PCBs and dioxins to analyze the associations between individual isomer levels and infant neurodevelopment. Because exposure to PCBs and dioxins can be reduced to prevent their adverse effects on children's development, even if the α error rate rises to some extent, we consider it important to catch these adverse effects on children's development. Therefore, we believe that analysis of the associations between PCBs and dioxins and children's development in this study was valuable.

In Japan, [@b20-ehp0114-000773] also performed a prospective study to elucidate the influence of an endocrine-disrupting chemical on the neurodevelopment of children. Humans are the main source of various chemical compounds that are known pollutants, and food seems to be the main source of PCBs and dioxins in background-level exposure. Because the intake of marine products, such as fish or iodine, in an island country such as Japan would be greater than in western countries, a risk evaluation based on domestic dioxin/PCB data is important.

[@b30-ehp0114-000773] pointed out that an improving tendency was shown in children of school age, even if there was a significant negative association between endocrine-disrupting chemical level and neurodevelopment of children during infancy. Breast-feeding and a good home environment are regarded as important factors that improve the influence. Additional studies are needed to elucidate these results still further.

This study was supported by a Grant-in-Aid for Health Scientific Research from the Japan Ministry of Health, Labour and Welfare, and by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.

###### 

Characteristics of mothers and infants (*n* = 134).

  Characteristic                                                                   No. (%)
  -------------------------------------------------------------------------------- -------------------------------------------------------------
  Maternal characteristics                                                         
   Age (years)                                                                     31.1 ± 4.7[a](#tfn1-ehp0114-000773){ref-type="table-fn"}
   Educational level (years)                                                       
    ≤ 9                                                                            5 (3.7)
    10--12                                                                         47 (35.1)
    13--16                                                                         80 (59.7)
    ≥ 17                                                                           2 (1.5)
  Economic status: annual income (yen)                                             
   \< 3,000,000                                                                    21 (15.7)
   3,000,000--5,000,000                                                            60 (44.8)
   5,000,000--7,000,000                                                            37 (27.6)
   7,000,000--10,000,000                                                           13 (9.7)
   \> 10,000,000                                                                   3 (2.2)
  Worked during pregnancy                                                          22 (16.4)
  Smoked during pregnancy                                                          18 (13.4)
  Fish intake during pregnancy                                                     
   Inshore fish                                                                    
    Rarely/never                                                                   8 (6.0)
    \< 1 time/week                                                                 67 (50.0)
    1--4 times/week                                                                58 (43.3)
    ≥ 5 times/week                                                                 1 (0.7)
   Deep-sea fish                                                                   
    Rarely/never                                                                   2 (1.5)
    \< 1 time/week                                                                 54 (40.3)
    1--4 times/week                                                                78 (58.2)
    ≥ 5 times/week                                                                 0
  Caffeine intake during pregnancy (mg/day)                                        140.6 ± 91.5[a](#tfn1-ehp0114-000773){ref-type="table-fn"}
  Alcohol intake before pregnancy (g/day)                                          19.7 ± 71.9[a](#tfn1-ehp0114-000773){ref-type="table-fn"}
  Alcohol intake during pregnancy (g/day)                                          0.9 ± 2.6[a](#tfn1-ehp0114-000773){ref-type="table-fn"}
  Blood sampling period                                                            
   During pregnancy                                                                86 (64.2)
   After delivery                                                                  48 (35.8)
  Child characteristics                                                            
   Sex                                                                             
    Male                                                                           68 (50.7)
    Female                                                                         66 (49.3)
   Gestational age (days)                                                          277.3 ± 8.1[a](#tfn1-ehp0114-000773){ref-type="table-fn"}
   Birth weight (g)                                                                3124.8 ±329.1[a](#tfn1-ehp0114-000773){ref-type="table-fn"}
   Length (cm)                                                                     48.2 ± 2.2[a](#tfn1-ehp0114-000773){ref-type="table-fn"}
   Head circumference (cm)                                                         33.4 ± 1.2[a](#tfn1-ehp0114-000773){ref-type="table-fn"}
   First-born                                                                      67 (50.0)
   Duration of breast-feeding, ≥ 3 months                                          78 (58.2)
   Age at testing (days)                                                           187.0 ± 4.4[a](#tfn1-ehp0114-000773){ref-type="table-fn"}
   BSID-II mental index score: MDI                                                 91.9 ± 5.8[a](#tfn1-ehp0114-000773){ref-type="table-fn"}
   BSID-II motor index score: PDI                                                  89.3 ± 10.5[a](#tfn1-ehp0114-000773){ref-type="table-fn"}
   Index of Child Care Environment[b](#tfn2-ehp0114-000773){ref-type="table-fn"}   22.7 ± 2.4[a](#tfn1-ehp0114-000773){ref-type="table-fn"}

Mean ± SD.

A perfect score is 30 points.

###### 

BSID-II mental (MDI) and psychomotor (PDI) development scores for infants in relation to mother and infant characteristics (*n* = 134).

                                                     MDI            PDI                                                                   
  -------------------------------------------- ----- -------------- ------------------------------------------------------ -------------- --------------------------------------------------------
  Maternal characteristics                                                                                                                
   Age (years)                                       *r* = 0.042    0.626                                                  *r* = −0.059   0.496
   Educational level                                                                                                                      
    ≤ 12 years                                 52    92.2 ± 5.0     0.647                                                  89.8 ± 10.8    0.676
    ≥ 13 years                                 82    91.7 ± 6.2                                                            89.0 ± 10.4    
   Economic status: annual income                                                                                                         
    \< 5,000,000 yen                           81    91.6 ± 5.8     0.444                                                  89.4 ± 10.4    0.875
    ≥ 5,000,000 yen                            53    92.3 ± 5.8                                                            89.1 ± 10.7    
   Worked during pregnancy                                                                                                                
    No                                         112   91.5 ± 5.7     0.107                                                  89.1 ± 10.3    0.697
    Yes                                        22    93.7 ± 6.0                                                            90.1 ± 11.8    
   Smoked during pregnancy                                                                                                                
    No                                         116   92.0 ± 5.8     0.469                                                  89.8 ± 10.6    0.183
    Yes                                        18    90.9 ± 5.8                                                            86.2 ± 9.1     
   Inshore fish intake during pregnancy                                                                                                   
    \< 1 time/week; rarely/never               75    91.6 ± 6.0     0.612                                                  88.9 ± 11.3    0.670
    ≥ 1 time/week                              59    92.2 ± 5.5                                                            89.7 ± 9.4     
   Deep-sea fish intake during pregnancy                                                                                                  
    \< 1 time/week; rarely/never               56    92.6 ± 5.3     0.198                                                  89.9 ± 10.6    0.542
    ≥ 1 time/week                              78    91.3 ± 6.0                                                            88.8 ± 10.5    
   Caffeine intake during pregnancy (mg/day)         *r* = −0.063   0.470                                                  *r* = −0.177   0.040[\*](#tfn4-ehp0114-000773){ref-type="table-fn"}
   Alcohol intake before pregnancy (g/day)           *r* = −0.050   0.564                                                  *r* = −0.099   0.256
   Alcohol intake during pregnancy (g/day)           *r* = 0.137    0.114                                                  *r* = 0.011    0.898
   Blood sampling time                                                                                                                    
    During pregnancy                           86    92.0 ± 5.5     0.767                                                  88.8 ± 10.3    0.472
    After delivery                             48    91.7 ± 6.3                                                            90.2 ± 10.9    
  Child characteristics                                                                                                                   
   Sex                                                                                                                                    
    Male                                       68    91.6 ± 5.8     0.595                                                  87.8 ± 9.9     0.084
    Female                                     66    92.1 ± 5.8                                                            90.9 ± 10.9    
   Gestational age (days)                            *r* = 0.178    0.039[\*](#tfn4-ehp0114-000773){ref-type="table-fn"}   *r* = 0.289    0.001[\*\*](#tfn5-ehp0114-000773){ref-type="table-fn"}
   Birth weight (g)                                  *r* = 0.103    0.237                                                  *r* = 0.086    0.323
   Length (cm)                                       *r* = 0.058    0.506                                                  *r* = −0.060   0.489
   Head circumference (cm)                           *r* = 0.071    0.416                                                  *r* = −0.015   0.862
   First-born                                                                                                                             
    Yes                                        67    92.3 ± 6.1     0.356                                                  89.7 ± 10.5    0.617
    No                                         67    91.4 ± 5.5                                                            88.8 ± 10.6    
   Duration of breast-feeding, ≥ 3 months                                                                                                 
    Yes                                        78    92.1 ± 6.0     0.557                                                  89.9 ± 10.5    0.422
    No                                         56    91.5 ± 5.5                                                            88.4 ± 10.5    
   Index of Child Care Environment                   *r* = −0.016   0.855                                                  *r* = −0.122   0.161

Student's *t*-test, Pearson's correlation coefficient test:

*p* \< 0.05;

*p* \< 0.01.

###### 

Level of PCBs and dioxins (pg/g lipid) in maternal blood (*n* = 134).

                                                         Detection limit[a](#tfn7-ehp0114-000773){ref-type="table-fn"}   Mean      Geometric mean   Minimum   25th[b](#tfn8-ehp0114-000773){ref-type="table-fn"}   50th[b](#tfn8-ehp0114-000773){ref-type="table-fn"}   75th[b](#tfn8-ehp0114-000773){ref-type="table-fn"}   Maximum
  ------------------------------------------------------ --------------------------------------------------------------- --------- ---------------- --------- ---------------------------------------------------- ---------------------------------------------------- ---------------------------------------------------- ---------
  PCDDs                                                                                                                                                                                                                                                                                                                      
   2,3,7,8-TCDD                                          1.0                                                             1.1       0.9              ND        ND                                                   1.1                                                  1.4                                                  3.1
   1,2,3,7,8-PeCDD                                       1.0                                                             4.4       3.9              ND        3.1                                                  4.2                                                  5.4                                                  11.9
   1,2,3,4,7,8-HxCDD                                     2.0                                                             1.8       1.6              ND        ND                                                   ND                                                   2.3                                                  13.6
   1,2,3,6,7,8-HxCDD                                     2.0                                                             15.5      13.7             2.4       10.4                                                 14.5                                                 18.3                                                 43.6
   1,2,3,7,8,9-HxCDD                                     2.0                                                             2.3       1.9              ND        ND                                                   2.2                                                  3.2                                                  7.4
   1,2,3,4,6,7,8-HpCDD                                   2.0                                                             26.0      24.0             9.6       18.2                                                 23.3                                                 31.5                                                 69.7
   OCDD                                                  4.0                                                             504.7     468.0            169.6     352.2                                                467.4                                                601.2                                                1491.5
  PCDFs                                                                                                                                                                                                                                                                                                                      
   2,3,7,8-TCDF                                          1.0                                                             0.7       0.6              ND        ND                                                   ND                                                   ND                                                   2.5
   1,2,3,7,8-PeCDF                                       1.0                                                             0.6       ND               ND        ND                                                   ND                                                   ND                                                   2.2
   2,3,4,7,8-PeCDF                                       1.0                                                             6.5       5.8              1.4       4.5                                                  6.0                                                  7.7                                                  19.9
   1,2,3,4,7,8-HxCDF                                     2.0                                                             2.6       2.3              ND        ND                                                   2.6                                                  3.3                                                  6.5
   1,2,3,6,7,8-HxCDF                                     2.0                                                             3.0       2.6              ND        2.2                                                  2.8                                                  3.7                                                  8.6
   2,3,4,6,7,8-HxCDF                                     2.0                                                             1.1       1.1              ND        ND                                                   ND                                                   ND                                                   5.0
   1,2,3,7,8,9-HxCDF                                     2.0                                                             ND        ND               ND        ND                                                   ND                                                   ND                                                   ND
   1,2,3,4,6,7,8-HpCDF                                   2.0                                                             3.1       2.4              ND        ND                                                   2.5                                                  3.4                                                  15.8
   1,2,3,4,7,8,9-HpCDF                                   2.0                                                             ND        ND               ND        ND                                                   ND                                                   ND                                                   ND
   OCDF                                                  4.0                                                             2.1       ND               ND        ND                                                   ND                                                   ND                                                   11.0
  Non-*ortho* PCBs                                                                                                                                                                                                                                                                                                           
   3,3′,4′,4′-TCB (77)                                   10.0                                                            13.2      11.9             ND        10.5                                                 12.8                                                 16.1                                                 37.2
   3,4,4′,5-TCB (81)                                     10.0                                                            ND        ND               ND        ND                                                   ND                                                   ND                                                   ND
   3,3′,4,4′,5-PeCB (126)                                10.0                                                            42.2      36.0             ND        26.0                                                 37.0                                                 54.9                                                 141.7
   3,3′,4,4′,5,5′-HxCB (169)                             10.0                                                            31.9      28.3             ND        21.5                                                 29.2                                                 36.6                                                 85.9
  Mono-*ortho* PCBs                                                                                                                                                                                                                                                                                                          
   2,3,3′4,4′-PeCB (105)                                 10.0                                                            1637.6    1418.8           256.1     976.2                                                1423.9                                               2044.1                                               5420.8
   2,3,4,4′,5-PeCB (114)                                 10.0                                                            407.2     353.3            79.3      248.6                                                363.9                                                488.5                                                1442.6
   2,3′,4,4′,5-PeCB (118)                                10.0                                                            6582.0    5691.3           1293.2    3912.5                                               5803.5                                               8192.7                                               20196.9
   2′,3,4,4′,5-PeCB (123)                                10.0                                                            127.8     109.4            24.3      70.3                                                 113.7                                                154.5                                                458.6
   2,3,3′,4,4′,5-HxCB (156)                              10.0                                                            2213.2    1942.1           441.5     1307.2                                               1982.9                                               2737.5                                               6427.8
   2,3,3′,4,4′,5′-HxCB (157)                             10.0                                                            557.2     485.4            85.1      333.3                                                507.0                                                675.4                                                1782.7
   2,3′,4,4′,5,5′-HxCB (167)                             10.0                                                            806.3     702.0            158.6     507.6                                                739.9                                                1005.0                                               2275.3
   2,3,3′,4,4′,5,5′-HpCB (189)                           10.0                                                            244.7     209.2            ND        138.1                                                222.7                                                312.0                                                625.8
  Di-*ortho* PCBs                                                                                                                                                                                                                                                                                                            
   2,2′,3,3′,4,4′,5-HpCB (170)                           10.0                                                            4518.4    3881.1           1104.9    2570.7                                               4155.7                                               5622.0                                               13620.5
   2,2′,3,4,4′,5,5′-HpCB (180)                           10.0                                                            13996.8   12063.7          2704.4    8392.9                                               12813.5                                              17957.1                                              41110.1
  Total                                                                                                                                                                                                                                                                                                                      
   Total PCDDs                                                                                                           547.8     511.1            192.8     389.5                                                508.9                                                646.9                                                1602.4
   Total PCDFs                                                                                                           42.7      21.1             10.4      16.6                                                 20.6                                                 24.5                                                 2877.3
   Total PCDDs/PCDFs                                                                                                     590.5     538.1            206.4     408.3                                                526.8                                                675.1                                                3726.3
   Total non-*ortho* PCBs                                                                                                91.4      83.7             27.4      64.2                                                 85.5                                                 110.3                                                269.9
   Total mono-*ortho* PCBs                                                                                               12575.9   11042.2          2832.8    7812.5                                               11471.6                                              15238.9                                              36382.2
   Total coplanar PCBs                                                                                                   12667.3   11131.1          2860.2    7868.6                                               11554.7                                              15352.0                                              36536.1
   Total                                                                                                                 13257.8   11770.9          3311.1    8431.7                                               12053.1                                              15845.5                                              37267.2
  WHO-98[c](#tfn9-ehp0114-000773){ref-type="table-fn"}                                                                                                                                                                                                                                                                       
   Total PCDD TEQ                                                                                                        7.7       7.0              1.6       5.3                                                  7.2                                                  9.4                                                  20.7
   Total PCDF TEQ                                                                                                        4.2       3.8              1.2       2.9                                                  3.8                                                  5.0                                                  12.4
   Total PCDD/PCDF TEQ                                                                                                   11.9      10.9             2.8       8.2                                                  11.2                                                 14.0                                                 31.2
   Total non-*ortho* PCB TEQ                                                                                             4.5       3.8              0.6       2.7                                                  3.9                                                  5.9                                                  15.0
   Total mono-*ortho* PCB TEQ                                                                                            2.5       2.2              0.6       1.6                                                  2.2                                                  2.9                                                  7.2
   Total coplanar PCB TEQ                                                                                                6.9       6.1              1.1       4.4                                                  6.2                                                  8.6                                                  22.2
   Total TEQ                                                                                                             18.8      17.2             4.0       13.4                                                 17.8                                                 23.4                                                 51.2

Abbreviations: ND, nondetectable; WHO, World Health Organization.

For subjects with a level below the detection limit, we used a value equal to half the detection limit.

Percentiles.

The calculation of TEQ was estimated based on the toxic equivalent factor values proposed by the WHO ([@b27-ehp0114-000773]).

###### 

BSID-II mental (MDI) and psychomotor (PDI) development scores for infants in relation to the level of PCBs and dioxins in maternal blood (*n* = 134).

                                                          MDI      PDI                                                                                  
  ------------------------------------------------------- -------- -------- --------------------------------------------------------- -------- -------- ---------------------------------------------------------
  PCDDs                                                                                                                                                 
   2,3,7,8-TCDD                                           −0.154   −1.755   0.083                                                     −0.125   −1.477   0.142
   1,2,3,7,8-PeCDD                                        0.074    0.847    0.398                                                     −0.063   −0.758   0.450
   1,2,3,4,7,8-HxCDD                                      −0.031   −0.352   0.725                                                     −0.135   −1.608   0.110
   1,2,3,6,7,8-HxCDD                                      0.033    0.365    0.716                                                     −0.074   −0.873   0.384
   1,2,3,7,8,9-HxCDD                                      0.006    0.067    0.946                                                     −0.209   −2.549   0.012[\*](#tfn13-ehp0114-000773){ref-type="table-fn"}
   1,2,3,4,6,7,8-HpCDD                                    −0.222   −2.418   0.017[\*](#tfn13-ehp0114-000773){ref-type="table-fn"}     −0.243   −2.806   0.006[\*\*](#tfn14-ehp0114-000773){ref-type="table-fn"}
   OCDD                                                   −0.177   −1.897   0.060                                                     −0.168   −1.895   0.060
  PCDFs                                                                                                                                                 
   2,3,7,8-TCDF                                           −0.053   −0.602   0.548                                                     −0.204   −2.516   0.013[\*](#tfn13-ehp0114-000773){ref-type="table-fn"}
   1,2,3,7,8-PeCDF                                        0.014    0.167    0.868                                                     −0.203   −2.512   0.013[\*](#tfn13-ehp0114-000773){ref-type="table-fn"}
   2,3,4,7,8-PeCDF                                        0.028    0.314    0.754                                                     −0.069   −0.822   0.413
   1,2,3,4,7,8-HxCDF                                      −0.113   −1.255   0.212                                                     −0.153   −1.807   0.073
   1,2,3,6,7,8-HxCDF                                      −0.101   −1.139   0.257                                                     −0.166   −1.989   0.049[\*](#tfn13-ehp0114-000773){ref-type="table-fn"}
   2,3,4,6,7,8-HxCDF                                      0.009    0.106    0.915                                                     −0.074   −0.875   0.383
   1,2,3,7,8,9-HxCDF                                      ND       ND       ND                                                        ND       ND       ND
   1,2,3,4,6,7,8-HpCDF                                    −0.038   −0.438   0.662                                                     −0.093   −1.123   0.264
   1,2,3,4,7,8,9-HpCDF                                    ND       ND       ND                                                        ND       ND       ND
   OCDF                                                   −0.057   −0.657   0.512                                                     −0.032   −0.385   0.701
  Non-*ortho* PCBs                                                                                                                                      
   3,3′,4′,4′-TCB (77)                                    0.032    0.357    0.721                                                     −0.023   −0.274   0.785
   3,4,4′,5-TCB (81)                                      ND       ND       ND                                                        ND       ND       ND
   3,3′,4,4′,5-PeCB (126)                                 −0.003   −0.032   0.975                                                     −0.138   −1.674   0.097
   3,3′,4,4′,5,5′-HxCB (169)                              0.013    0.147    0.884                                                     −0.097   −1.181   0.240
  Mono-*ortho* PCBs                                                                                                                                     
   2,3,3′,4,4′-PeCB (105)                                 −0.004   −0.047   0.963                                                     −0.112   −1.366   0.174
   2,3,4,4′,5-PeCB (114)                                  −0.024   −0.277   0.782                                                     −0.132   −1.607   0.111
   2,3′,4,4′,5-PeCB (118)                                 −0.016   −0.182   0.856                                                     −0.137   −1.671   0.097
   2′,3,4,4′,5-PeCB (123)                                 0.033    0.379    0.705                                                     −0.108   −1.307   0.194
   2,3,3′,4,4′,5-HxCB (156)                               0.001    0.008    0.994                                                     −0.099   −1.201   0.232
   2,3,3′,4,4′,5′-HxCB (157)                              −0.038   −0.431   0.667                                                     −0.141   −1.723   0.087
   2,3′,4,4′,5,5′-HxCB (167)                              −0.012   −0.140   0.889                                                     −0.135   −1.652   0.101
   2,3,3′,4,4′,5,5′-HpCB (189)                            −0.102   −1.182   0.239                                                     −0.136   −1.662   0.099
  Di-*ortho* PCBs                                                                                                                                       
   2,2′,3,3′,4,4′,5-HpCB (170)                            −0.027   −0.310   0.757                                                     −0.132   −1.612   0.109
   2,2′,3,4,4′,5,5′-HpCB (180)                            −0.021   −0.246   0.806                                                     −0.086   −1.042   0.299
  Total                                                                                                                                                 
   Total PCDDs                                            −0.234   −2.649   0.009[\*\*](#tfn14-ehp0114-000773){ref-type="table-fn"}   −0.144   −1.686   0.094
   Total PCDFs                                            −0.048   −0.535   0.594                                                     0.071    0.833    0.407
   Total PCDDs/PCDFs                                      −0.220   −2.485   0.014[\*](#tfn13-ehp0114-000773){ref-type="table-fn"}     −0.090   −1.046   0.298
   Total non-*ortho* PCBs                                 0.032    0.365    0.716                                                     −0.006   −0.076   0.939
   Total mono-*ortho* PCBs                                −0.014   −0.165   0.869                                                     −0.136   −1.663   0.099
   Total coplanar PCBs                                    −0.013   −0.155   0.877                                                     −0.135   −1.650   0.101
   Total                                                  −0.022   −0.247   0.805                                                     −0.130   −1.584   0.116
  WHO-98[b](#tfn12-ehp0114-000773){ref-type="table-fn"}                                                                                                 
   Total PCDD TEQ                                         0.046    0.522    0.603                                                     0.004    0.043    0.966
   Total PCDF TEQ                                         0.016    0.182    0.856                                                     0.057    0.671    0.503
   Total PCDDs/PCDF TEQ                                   0.037    0.419    0.676                                                     0.032    0.378    0.706
   Total non-*ortho* PCB TEQ                              0.020    0.233    0.816                                                     −0.017   −0.204   0.838
   Total mono-*ortho* PCB TEQ                             −0.011   −0.123   0.902                                                     −0.127   −1.544   0.125
   Total coplanar PCB TEQ                                 0.032    0.371    0.711                                                     −0.053   −0.636   0.526
   Total TEQ                                              0.049    0.550    0.583                                                     0.007    0.080    0.936

Abbreviations: ND, nondetectable; WHO, World Health Organization.

β is the point increase in developmental score per PCB and dioxin level (natural logarithm) adjusted for gestational age (days), smoking during pregnancy, caffeine intake during pregnancy (mg/day), and blood sampling time.

The calculation of TEQ was estimated based on the toxic equivalent factor values proposed by the WHO ([@b27-ehp0114-000773]).

*p* \< 0.05;

*p* \< 0.01.
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